Tired without answers? Years‑long limbo may be nearing its end as scientists spotlight measurable clues behind relentless ...

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced another successful ...

Parkinson’s disease (PD) remains one of the most challenging neurodegenerative disorders to diagnose and monitor.

CHICAGO--(BUSINESS WIRE)--Contrast enhanced ultrasound (CEUS) is superior to contrast magnetic resonance (MR) and computed tomography (CT), and offers 100% sensitivity and specificity, for finding ...

Diagnostic company Exact Sciences Corporation (NASDAQ:EXAS) reported in Q3 CY2025, with sales up 20% year on year to $850.7 ...

For years, people with crushing fatigue have fought for answers, bouncing between clinics and labels that never quite fit well. A team from the University ...

Exact Sciences Corp (EXAS) reports robust financial performance and raises full-year guidance, driven by strong screening ...

Use of Thermal Ablation in Low-Resource Settings: Experience From Three Multicenter Noninferiority Randomized Clinical Trials Women living with and without HIV, age 30-65 years, were recruited in ...

The resulting 124 I-evuzamitide (previously known as AT-01) has been shown to detect amyloidosis in organs like the heart, liver, and kidney. Previous work also showed that this amyloid-specific PET ...

Syncell Inc., the nanoscopic proteomics company, announced the launch of its Synlight-Pure™ Kit, an ultra-high-precision ...